Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $117,674 (100.0% shares, 0.0% debt)

Holdings (19)

— Abeona Therapeutics Inc 32.1%

Value ($000) $37,756 Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Biohaven Pharmactl Hldg Co L 25.2%

Value ($000) $29,633 Shares 749,815 Est. Cost $25.00 Unrealized —

— Corbus Pharmaceuticals HLDGS 16.8%

Value ($000) $19,765 Shares 3,913,874 Est. Cost $4.42 Unrealized —

— Electrocore Inc 5.6%

Value ($000) $6,551 Shares 396,825 Est. Cost $16.51 Unrealized —

— Ampio Pharmaceuticals Inc. 4.9%

Value ($000) $5,710 Shares 2,595,484 Est. Cost $6.03 Unrealized —

KRYS Krystal Biotech Inc 3.8%

Value ($000) $4,461 Shares 300,000 Est. Cost $10.08 Unrealized +11.3%

ENTX Entera Bio Ltd 2.5%

Value ($000) $2,996 Shares 475,540 Est. Cost $6.29 Unrealized 0.0%

— Galmed Pharmaceuticals Ltd 2.1%

Value ($000) $2,499 Shares 210,000 Est. Cost $11.90 Unrealized —

— Vascular Biogenics LTD 1.7%

Value ($000) $1,973 Shares 896,771 Est. Cost $4.71 Unrealized —

AVXL Anavex Life Sciences Corp 1.6%

Value ($000) $1,897 Shares 724,205 Est. Cost $3.56 Unrealized -21.6%

ALDX Aldeyra Therapeutics Inc 0.8%

Value ($000) $987 Shares 124,096 Est. Cost $10.20 Unrealized -21.8%

— Eiger Biopharmaceuticals Inc 0.8%

Value ($000) $918 Shares 75,238 Est. Cost $9.85 Unrealized —

— Soligenix Inc. 0.7%

Value ($000) $813 Shares 837,800 Est. Cost $2.11 Unrealized —

VNRX Volition RX LTD 0.6%

Value ($000) $703 Shares 351,538 Est. Cost $3.75 Unrealized -40.4%

— Evoke Pharma Inc 0.6%

Value ($000) $688 Shares 275,000 Est. Cost $2.99 Unrealized —

NAGE Chromadex Corp 0.2%

Value ($000) $178 Shares 47,866 Est. Cost $3.80 Unrealized 0.0%

— Lipocine Inc New 0.1%

Value ($000) $65 Shares 50,000 Est. Cost $1.30 Unrealized —

— Catasys Inc 0.1%

Value ($000) $61 Shares 9,081 Est. Cost $6.72 Unrealized —

— Advaxis Inc. 0.0%

Value ($000) $20 Shares 112,500 Est. Cost $3.96 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Abeona Therapeutics Inc	2,359,767	$37,756	32.1%	$4.97	—	COM	00289Y107
—	Biohaven Pharmactl Hldg Co L	749,815	$29,633	25.2%	$25.00	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	3,913,874	$19,765	16.8%	$4.42	—	COM	21833P103
—	Electrocore Inc	396,825	$6,551	5.6%	$16.51	—	COM	28531P103
—	Ampio Pharmaceuticals Inc.	2,595,484	$5,710	4.9%	$6.03	—	COM	03209T109
KRYS	Krystal Biotech Inc	300,000	$4,461	3.8%	$10.08	+11.3%	COM	501147102
ENTX	Entera Bio Ltd	475,540	$2,996	2.5%	$6.29	0.0%	SHS	M40527109
—	Galmed Pharmaceuticals Ltd	210,000	$2,499	2.1%	$11.90	—	SHS	M47238106
—	Vascular Biogenics LTD	896,771	$1,973	1.7%	$4.71	—	COM	M96883109
AVXL	Anavex Life Sciences Corp	724,205	$1,897	1.6%	$3.56	-21.6%	COM NEW	032797300
ALDX	Aldeyra Therapeutics Inc	124,096	$987	0.8%	$10.20	-21.8%	COM	01438T106
—	Eiger Biopharmaceuticals Inc	75,238	$918	0.8%	$9.85	—	COM	28249U105
—	Soligenix Inc.	837,800	$813	0.7%	$2.11	—	COM	834223307
VNRX	Volition RX LTD	351,538	$703	0.6%	$3.75	-40.4%	COM	928661107
—	Evoke Pharma Inc	275,000	$688	0.6%	$2.99	—	COM	30049G104
NAGE	Chromadex Corp	47,866	$178	0.2%	$3.80	0.0%	COM NEW	171077407
—	Lipocine Inc New	50,000	$65	0.1%	$1.30	—	COM	53630X104
—	Catasys Inc	9,081	$61	0.1%	$6.72	—	COM	149049504
—	Advaxis Inc.	112,500	$20	0.0%	$3.96	—	W EXP 07/15/201	007624117